Finance ForgeBETA
Crear cuenta gratis
1)Empresas2)Rankings3)Iniciar sesión
Finance Forge Terminal v1.51.3
PrivacidadTérminosCookiesAviso Legal
● Connected
MMED US Equity
MiniMed Group, Inc.
18.40USD▼ 2.13%
Healthcare
Medical Instruments & Supplies
96)Comparar97)Tesis →
Market Cap
$5.2B
Shares Outstanding
281M
Net Income (TTM)
−$309M
— Annual —FY2026
Revenue
$3.1B
Gross Margin
54.2%
Operating Margin
-6.1%
Net Margin
-10.7%
FCF Margin
-13.5%
ROE
-9.2%
ROCE
-4.8%
Current Ratio
1.92
FCF / Share
-1.49
Book Value / Share
12.83
MMED US Equity
18.40USD▼ 2.13%
Tesis →

MiniMed Group, Inc. (MMED): análisis fundamental y valoración

MiniMed Group, Inc. cotiza a 18.40 USD y tiene una capitalización bursátil de $5.2B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud

Price History
Loading...
Perfil
BolsaNasdaqPaísUnited StatesEmpleados8,000Web↗ www.minimed.com

MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and relate…

Múltiplos de Valoración
P/E (Annual)
—
P/E (TTM)
—
P/FCF (Annual)
—
P/FCF (TTM)
—
EV/EBITDA
—
EV/Revenue
—
P/Sales
1.7×
P/Book
1.4×
Rentabilidad (Último Anual)
Gross Margin
54.2%
Operating Margin
-6.1%
Net Margin
-10.7%
FCF Margin
-13.5%
ROE
-9.2%
ROCE
-4.8%
ROA
-7.2%
Effective Tax Rate
—
Métricas TTM
Revenue TTM
—
Gross Profit TTM
—
Operating Income TTM
—
Net Income TTM
−$309M
FCF TTM
—
EPS TTM
—
Quarters Used
4
TTM Period
2025-10-24 → 2026-07-31
Solidez del Balance
Net Debt
—
Net Debt / EBITDA
—
Debt / Equity
—
Current Ratio
1.92
Interest Coverage
—
Working Capital
$646M
Book Value / Share
12.83
Net Debt / Share
—
Crecimiento (YoY)
Revenue YoY
+14.3%
Net Income YoY
-56.3%
FCF YoY
-692.5%
EPS Diluted YoY
-54.8%
Retorno al Accionista
Dividend Yield
—
Payout Ratio
—
FCF / Share
-1.49
CapEx % Revenue
7.2%
Rev / Employee
387,750
Historial EPS
Periodo2026-112026-092026-062026-04
Real—$0.13$-0.60$0.08
Estimado$0.12$0.10$-0.22$0.21
Sorpresa—+30.0%-172.7%-61.9%
Empresas similares
Smart Money
vs Sector: Healthcare (1130 empresas)
MétricaMMEDMediana SectorΔ
Gross Margin54.2%57.0%-2.9%
Operating Margin-6.1%-38.6%+32.5%
Net Margin-10.7%-33.6%+22.8%
FCF Margin-13.5%-13.9%+0.3%
ROE-9.2%-40.4%+31.2%
ROA-7.2%-32.0%+24.8%
Current Ratio1.922.84-0.92
Debt / Equity—0.28—
Scoring Fundamental
Piotroski F-Score
3/ 8Débil
✗F1ROA positivo (rentabilidad activos)
✗F2Flujo caja operativo positivo
✗F3ROA mejora vs año anterior
✓F4Calidad de beneficios (OCF > ROA)
✗F5Apalancamiento baja
✓F6Liquidez mejora (current ratio)
✗F7Sin dilución accionarial
✗F8Margen bruto mejora
✓F9Rotación activos mejora
Altman Z-ScoreZona Segura
3.71
x1_working_capital0.140
x2_retained_earnings-0.025
x3_ebit-0.041
x4_market_equity5.080
x5_sales0.670
>2.99 segura · 1.81–2.99 gris · <1.81 riesgo
Capital Allocation
2/ 8Débil
✗FCF+Free cash flow positivo
✗FCFmMargen FCF > 10%
✓DilucSin dilución significativa (< 2%/año en 3 años)
✗Rev↑Revenue CAGR 3 años > 5%
✗ROCERetorno sobre capital empleado > 10%
✗DeudaDeuda neta/EBITDA < 3× (o posición de caja neta)
✗Mg↑Margen operativo ≥ hace 2-3 años (tolerancia -2pp)
✓Inv.R&D + Capex > 3% de revenue (reinversión en el negocio)
Histórico Piotroski F-Score
Histórico de Múltiplos